Most Men With Breast Cancer Undergo Mastectomy, Study Finds

In In The News by Barbara Jacoby

From: HealthDay News By Maureen Salamon Breast cancer in men occurs only rarely. But among men who have breast cancer, mastectomy rather than breast-conserving surgery is by far the more common choice, new research shows. Scientists used a national database to compare treatment and outcomes between women and men with breast cancer. They found that males undergo mastectomy surgery far …

Most Teens Who Misuse Painkillers Aren’t After a High, Study Finds

In In The News by Barbara Jacoby

From: Drugs.com Most teens who misuse narcotic painkillers hope to get relief from pain, a new study reveals. Researchers found that four out of five teens who misused prescription pain medications such as OxyContin or Vicodin by taking more than directed or using someone else’s prescription cared less about getting high than they did about easing their discomfort. Although research …

No Good Data For or Against Taking Vitamins, Experts Say

In In The News by Barbara Jacoby

From: Drugs.com Even though millions of Americans pop a vitamin, mineral or multivitamin supplement every day, an influential government-appointed panel of experts says the jury is still out on whether they help boost health or not. In its draft guidelines, the U.S. Preventive Services Task Force said that in some cases, certain supplements, such as beta carotene or vitamin E, …

Take Aspirin at Bedtime to Better Protect Your Heart, Study Suggests

In In The News by Barbara Jacoby

From: Drugs.com A daily dose of aspirin has become a common treatment for people at high risk for heart attacks or strokes, because it thins the blood and prevents clots from forming. But does it matter when during the day you take the drug? A new Dutch study suggests that people who take aspirin at bedtime might get more protection …

FDA Approves Imbruvica for Mantle Cell Lymphoma

In In The News by Barbara Jacoby

From: Drugs.com The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer. MCL is a rare form of non-Hodgkin lymphoma and represents about 6 percent of all non-Hodgkin lymphoma cases in the United States. By the time MCL is diagnosed, it usually has already …

Malaria Drug (Furamidine) To Treat Cancer

In In The News by Barbara Jacoby

From: The Global Innovations A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found. Researchers discovered that simple modifications to the drug furamidine have a major impact on its ability to affect specific human proteins involved in the on-off switches of certain …

‘One-Stop’ Radiation Treatment Might Offer Breast Cancer Care Alternative

In In The News by Barbara Jacoby

From: Drugs.com Some women with early breast cancer might benefit from a “one-and-done” treatment, in which they receive a single dose of targeted radiation therapy during the surgery that removes their tumor. A pair of new studies found that this procedure works about as well as current protocols that require six weeks of daily radiation therapy following surgery. The new …

Surprises in hunt for environmental links to breast cancer

In In The News by Barbara Jacoby

As posted on Channel NewsAsia WASHINGTON: A decade-long research effort to uncover the environmental causes of breast cancer by studying both lab animals and a group of healthy US girls has turned up some surprises, scientists say. At the centre of the investigation are 1,200 school girls who do not have breast cancer, but who have already given scientists important …

Early stages of breast cancer could soon be diagnosed from blood samples

In In The News by Barbara Jacoby

What could someday be the first blood test for the early detection of breast cancer was shown in preliminary studies to successfully identify the presence of breast cancer cells from serum biomarkers, say the Houston Methodist Research Institute scientists who are developing the technology. With a New York University Cancer Institute colleague, the researchers report in an upcoming Clinical Chemistry …

IceCure Medical Ltd. announces treatment of first breast cancer patient using its IceSense3

In In The News by Barbara Jacoby

From: The Wall Street Journal IceCure Medical Ltd. (TASE: ICCM) announced today that the John Wayne Cancer Institute (JWCI) at Saint John’s Health Center in Santa Monica, CA, treated its first breast cancer patient using the IceSense3 Cryoablation System in a pilot study evaluating immune responses in patients with operable breast cancer. In this pilot study, patients undergo cryoablation of …